Cystic Fibrosis Foundation

Analysis

Cystic Fibrosis Foundation is a registered charity in United States, based in Bethesda, MD. It received its IRS tax-exemption ruling in November 1957, 69 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Cystic Fibrosis Foundation reported income of $292.0m and spending of $443.4m, spending 152% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income fell from $605.8m to $292.0m (-52%), an average of -17% a year. The sharpest change came in the year to December 2021, when income dropped by 48%. Over the whole period it spent 82% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Cystic Fibrosis Foundation sits at the 97th percentile: it is larger than about 97% of them. Against every charity in United States with reported income it ranks in the 100th percentile, and in the 100th percentile within MD. Charities of a similar size with the same main cause include Sheppard Pratt Health System Inc ($291.9m), Mercy Clinic Springfield Communities ($292.1m) and White County Medical Center ($291.4m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 30% and program service revenue 1.2% of the total. Compensation of current officers, directors and key employees was $7.1m (1.6% of expenses). Other salaries and wages came to $90.4m. It paid $176k in professional fundraising fees. At year end it held assets of $4.89bn against liabilities of $293.0m, net assets of $4.59bn. It reported 847 employees.